Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22592094 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin

Indicates status has not been verified in more than two years